Transfusionassociated graftversushost disease tagvhd is a dreaded complication in immunocompromized hosts. Prevention of transfusionassociated graftversushost. The only effective preventive measure is administration of irradiated blood. Introduction rare complication due to transfusion of lymphocyte containing blood products. Editor,ahya et al reported a case of transfusion associated graft versus host disease tagvhd in a nonimmunocompromised patient resulting from blood transfusion after coronary artery bypass grafting cabg. Cristina navarrete page 2 of 10 purposes recommendations for the investigation and provision of clinical advice in cases of suspected or proven transfusionassociated graftversushost disease. Transfusion associated graft versus host disease tagvhd is a rare complication of blood transfusion, in which the immunologically competent donor t lymphocytes mount an immune response against the recipients lymphoid tissue. Transfusion associated graft versus host disease gvhd is a rare condition that can occur after receipt of any cellular blood component with viable lymphocytes. In immunocompetent hosts, tagvhd has been observed after the transfusion of cellular components from hlahomozygous donors to recipients heterozygous for that human leukocyte antigen hla haplotype. Transfusionassociated graftvshost disease tagvhd is a rare but usually fatal complication of transfused cellular blood components. Tagvhd is a syndrome similar to gvhd induced by bone marrow transplantation.
Transfusionassociated graftversushost disease tagvhd is a rare and usually fatal complication of blood transfusion in which lymphocytes from the transfused blood component attack the recipients tissues, especially the. Transfusion associated graftversushost disease tagvhd is a rare, but almost universally fatal, iatrogenic. Hlamatched blood products and posttransfusion graft versus host disease. Transfusionassociated graftversushost disease template version 071008 authors.
The groups at risk for development of transfusion associated graft vs host disease, the clinical presentation and course, and methods of diagnosis are summarized. Gvhd also applies to other forms of transplanted tissues such as solid organ transplants. The inherent risk associated with an individual transfusion depends on the interplay of several factors, including the number and viability of contaminating lymphocytes in the transfused cellular. However, in situations where the recipient is immunocompromised. Transfusion associated graft versus host disease tagvhd is a fatal complication of blood transfusion and is accounted for 90% to 100% mortality 1. The present study evaluated the efficacy of pct to prevent transfusionassociated graftversushost disease tagvhd in vivo using a wellcharacterized parent to f 1 murine transfusion model. Its diagnosis is complicated, and staging of the disease varies dependent upon the transplant centre involved. It is seen usually in immunosuppressed individuals due to engraftment of viable t lymphocytes but it may also occur in immunocompetent individuals. The diagnosis was established by hla typing and str analysis of the patient and her family. Pdf transfusion associated graft versus host disease. Anticd3 antibody ameliorates transfusionassociated graft. Hamid nawaz tipu1, tahir aziz ahmed2, khalilullah3, suhaib ahmed4, tariq satti5, pervaiz ahmed6. Graft versus host disease gvhd is a syndrome, characterized by inflammation in different organs, with the specificity of epithelial cell apoptosis and crypt drop out.
However, in situations where the recipient is immunocompromised inborn immunodeficiency. Transfusionassociated graftversushost disease wikipedia. Transfusionassociated graftversushost disease is a clinical diagnosis and should be suspected following a transfusion in the presence of fever, rash, liver dysfunction and gastrointestinal symptoms. Transfusionassociated graftversushost disease is defined by the us national healthcare safety network as fever, rash, hepatomegaly, diarrhea between 2 days and 6 weeks after transfusion with laboratory evidence of liver dysfunction, pancytopenia, leukocyte chimerism, and findings of tagvhd on skin or liver biopsy. In this report, we discuss tagvhd from a historical.
Survey of irradiation practice for the prevention of. Transfusionassociated graftversushost disease tagvhd is a rare immunemediated complication of transfusion that is associated with high mortality. Transfusion associated graft versus host disease tagvhd is a severe disease resulting from the transfusion of immunocompetent t lymphocytes present in platelet concentrates into an immunocompromised host, although it can rarely also occur in immunocompetent hosts. Risk of transfusion associated graft versus host disease as a result of directed donations from relatives. Mar 27, 2017 transfusion associated graft versus host disease tagvhd is a disease with a very high mortality rate. Transfusion associated graft versus host disease is a rare but usually fatal complication of transfusion of cellular blood components, caused by multiorgan engraftment and proliferation of donor t lymphocytes. This chapter provides information regarding the immune pathophysiology and clinical implications of tagvhd and explores both longstanding and emerging interventions that reduce the risk of ta. The main clinical features of this transfusion reaction are pancitopenia and multiorgan failure skin, liver, gut. Graftversushost disease and transfusionassociated graft. Transfusionassociated graftversushost disease tagvhd represents a rare fatal event observed in immunocompromised patients and. Transfusionassociated graftversushost disease ucsf clinical.
The present study evaluated the efficacy of pct to prevent transfusion associated graft versus host disease tagvhd in vivo using a wellcharacterized parent to f 1 murine transfusion model. If i need to have a blood transfusion, cellular blood components red cells, platelets and granulocytes must be irradiated i am at risk of transfusionassociated graftversushost disease this patient is at risk of transfusionassociated graftversushost disease please inform the blood transfusion laboratory if this patient needs to have a. Transfusion associated graft versus host disease an. Transfusion associated graft versus host disease template version 071008 authors. Report for the south west regional transfusion committee sw rtc the british committee for standards in haematology bcsh guidelines for the gamma irradiation of blood components for the prevention of transfusion associated graft versus host disease tagvhd 1996 states.
Graftversushost disease is commonly observed after allogeneic bone marrow transplantation but rarely recognized after transfusion or solidorgan transplantation. Transfusion associated graft versus host disease tagvhd is a rare but lethal complication of transfusion,1 generally associated with immunosuppressed patients. Armed forces institute of pathology1,2,4, armed forces institute of bone marrow transplantation3,5,6, rawalpindi. Transfusionassociated graftversushost disease in ataxia. As described in the case report in this issue,2 however, the condition can occur in fully immunocompetent individuals, with the onset of symptoms usually 12 weeks after transfusion. Pdf transfusion associated graft versus host disease following. Cristina navarrete page 2 of 10 purposes recommendations for the investigation and provision of clinical advice in cases of suspected or proven transfusion associated graft versus host disease. The transfer of pathogens and the induction of immune responses are deleterious consequences that can result from the transfusion of blood products. Report for the west midlands regional transfusion committee wm rtc the british committee for standards in haematology bcsh guidelines for the gamma irradiation of blood components for the prevention of transfusionassociated graftversushost disease tagvhd 1996 states.
Transfusionassociated graftversushost disease in a. Introduction transfusion associated graft versus host disease tagvhd is a dreadful and one of the most feared complications of blood. Risk of transfusionassociated graftversushost disease as a result of directed donations from relatives. Immunosuppressive patients who receive blood transfusion containing immune. As described in the case report in this issue,2 however, the condition can occur in fully immunocompetent individuals, with the onset of symptoms usually 12 weeks after. T cells in the donor blood trigger an inflammatory reaction in the patients body. Transfusion associated graftversushost disease tagvhd. The diagnosis is often delayed because of lack of awareness and the nonspecific clinical features. The role of blood from hlahomozygous donors in fatal transfusionassociated graftversushost disease after openheart surgery.
The clinical course is stormy with a high mortality rate. The classical features of skin rash, diarrhoea and hepatitis, along with striking bonemarrow failure, are seen 12 weeks after. Prevention of transfusionassociated graftversushost disease. Transfusionassociated graftvshost disease in patients. Transfusion associated graft versus host disease 14. It can occur in immunocompromised as well as immunocompetent hosts and may follow allogeneic bone marrow transplant or transfusion from a related donor. Transfusionassociated graftversushost disease tagvhd is a rare, usually fatal, complication of blood transfusion wherein donor lymphocytes in a transfused blood component mount an immunodestructive response against recipient tissues. There is no doubt that diagnosing this condition needs a. Preventing transfusion associated graft versus host disease. Transfusionassociated graftversushost disease tagvhd is a rare, but almost universally fatal, iatrogenic complication of transfusion. Preventing transfusionassociated graftversushost disease.
Transfusion associated graft versus host disease tagvhd. Gvhd is a rare, often fatal complication of blood transfusion that. Transfusion associated graft versus host disease tagvhd is a rare immunemediated complication of transfusion that is associated with high mortality. Transfusion associated graft vs host disease tagvhd is a rare but usually fatal complication of transfused cellular blood components. Australian and new zealand society of blood transfusion ltd. Transfusion associated graft versus host disease tagvhd is a wellknown but rare complication that follows infusion of histoincompatible lymphoid cells, often seen in.
Transfusion associated graft versus host disease authors. Prevention of this highly fatal condition is possible by irradiation of blood products given to patients at risk, but problems remain in determining the groups that warrant such measures. Colin brown page 3 of 10 1 introduction tagvhd is a devastating but almost entirely preventable complication of transfusion. Transfusionassociated graftversushost disease schroeder. Transfusionassociated graftversushost disease tagvhd. By continuing to use our website, you are agreeing to our use of cookies. A rare but lifethreatening complication, transfusionassociated graftversushost disease occurs when an immunosuppressed or immunodeficient patient receives a blood transfusion from an immunocompetent donor.
Aug 21, 2016 transfusion associated graft versus host disease 14. Guidelines for prevention of transfusionassociated graft. Patients present with fever, skin rash, diarrhoea, hepatic. Transfusion associated graft versus host disease tagvhd is a rare but usually fatal complication of transfusion of cellular blood products. In this report, we discuss tagvhd from a historical perspective, highlight the pathogenesis of tagvhd, and emphasize the importance of blood product irradiation, which is a very effective means to prevent this disease.
Pdf transfusionassociated graftversushost disease reexamined. Transfusionassociated graftversushost disease gvhd is a rare condition that can occur after receipt of any cellular blood component with viable lymphocytes. Transfusionassociated graftversushost disease tagvhd is a disease with a very high mortality rate. Pdf graftversushost disease gvhd is a wellknown complication of allogeneic bone marrow transplantation. Twelve cases were reported to the serious hazards of transfusion shot scheme during the first four years of reporting1,2. Methods a search of medline articles published since 1960 was performed using the key words. Transfusionassociated graftversushost disease tagvhd is a rare and usually fatal complication of blood transfusion in which lymphocytes from the transfused blood component attack the recipients tissues, especially the skin, bone marrow, and gastrointestinal tract.
The groups at risk for development of transfusionassociated graftvshost disease, the clinical presentation and course, and methods of diagnosis are summarized. Transfusionassociated graftversushost disease uptodate. However, no mention is made of the occurrence of graftversushost disease in patients who receive donorspecific blood transfusions before transplantation from. Acute and chronic graft versus host disease gvhd is a major cause of morbidity and mortality in patients who undergo allogeneic haematopoietic cell transplantation hct and affects approximately 3040% of recipients. More than 90% patients succumb to refractory infections.
Irradiation of blood components for the prevention of. Fifty percent of tagvhd cases occur in patients who would not be. Graftversushost disease gvhd is a syndrome, characterized by inflammation in different organs, with the specificity of epithelial cell apoptosis and crypt drop out. Report for the south west regional transfusion committee sw rtc the british committee for standards in haematology bcsh guidelines for the gamma irradiation of blood components for the prevention of transfusionassociated graftversushost disease tagvhd 1996 states. If i need to have a blood transfusion, cellular blood components red cells, platelets and granulocytes must be irradiated i am at risk of transfusion associated graft versus host disease this patient is at risk of transfusion associated graft versus host disease please inform the blood transfusion laboratory if this patient needs to have a. Transfusionassociated graftversushost disease tagvhd is a fatal complication of blood transfusion and is accounted for 90% to 100% mortality 1. Transfusionassociated graftversushost disease tagvhd is a rare complication of blood transfusion, in which the donor t lymphocytes mount an immune response against the recipients lymphoid tissue. Transfusionassociated graftversushost diseas we use cookies to enhance your experience on our website.
Death typically occurring within weeks of first symptoms, most commonly due to overwhelming infections. Confirmation of gvhd, whether due to bmt or transfusion, can be supported by biopsies from the skin most commonly, liver or bowel. Gvhd is a rare, often fatal complication of blood transfusion that can. Transfusion associated graft versus host disease heart. Transfusionassociated graftversushost disease tagvhd is a severe disease resulting from the transfusion of immunocompetent t lymphocytes present in platelet concentrates into an immunocompromised host, although it can rarely also occur in immunocompetent hosts. Transfusionassociated graftversushost disease nejm. Tagvhd is caused by transfused bloodderived, alloreactive t lymphocytes that attack host tissue, including bone marrow with resultant bone. Thaler m, shamiss a, orgad s, huszar m, nussinovitch n, meisel s, gazit e, lavee j, smolinsky a. Transfusionassociated graftversushost disease tagvhd which is characterised by fever, maculopapular skin rash, diarrhoea, hepatitis, and bone marrow failure is most commonly, but not exclusively, encountered in individuals with severe congenital or acquired immunodeficiency1 following the transfusion of cellular blood components containing immunocompetent cells. Gvhd is commonly associated with stem cell transplants such as those that occur with bone marrow transplants. Donor lymphocytes are usually identified as foreign and destroyed by the recipients immune system. Transfusionassociated graftversushost disease tagvhd represents a rare fatal event observed in immunocompromised patients and immunocompetent individuals.
Transfusion associated graft versus host disease tagvhd is a rare complication of blood transfusion, in which the donor t lymphocytes mount an immune response against the recipients lymphoid tissue. Charpentier f, bracq c, bonin p, berling p, duedari n. Tagvhd leads to profound marrow aplasia with a mortality rate 90%. Recipient mice in four treatment groups were transfused with 10 8 splenic leukocytes.
Symptoms occur up to 30 days after the blood transfusion. Transfusionassociated graftversushost disease and its. Transfusion associated graft versus host disease tagvhd is a wellknown but rare complication that follows infusion of histoincompatible lymphoid cells, often seen in individuals with impaired. Transfusion associated graft versus host disease tagvhd is a dreaded complication in immunocompromized hosts. Transfusionassociated graftvshost disease in patients with. Gvhd also applies to other forms of transplanted tissues such as. Transfusion associated graft versus host disease tagvhd is a rare, but almost universally fatal, iatrogenic complication of transfusion. Transfusion associated graft versus host disease is defined by the us national healthcare safety network as fever, rash, hepatomegaly, diarrhea between 2 days and 6 weeks after transfusion with laboratory evidence of liver dysfunction, pancytopenia, leukocyte chimerism, and findings of tagvhd on skin or liver biopsy. Transfusionassociated graftversushost disease authors. Transfusion associated graft versus host disease tagvhd is a rare and usually fatal complication of blood transfusion in which lymphocytes from the transfused blood component attack the recipients tissues, especially the skin, bone marrow, and gastrointestinal tract. Transfusionassociated graftversushost disease tagvhd is an underdiagnosed condition in clinical practice. Graft versus host disease is commonly observed after allogeneic bone marrow transplantation but rarely recognized after transfusion or solidorgan transplantation.
Hlamatched blood products and posttransfusion graftversushost disease. Transfusionassociated graftversushost disease tagvhd is a rare. Transfusion associated graft versus host disease and its. This serious transfusion associated adverse reaction will be described in this series of articles.
1275 845 971 1528 395 1539 264 1186 31 1105 701 1617 498 1077 668 1127 1417 1155 922 1495 1436 1573 1032 349 556 227 1441 1162 1276 1028 1248 399 985 258 200 837 1126 334 295 1463 694 980